<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000405883"><TermName>NSC 655649</TermName><TermDefinition><DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the families of drugs called antitumor antibiotics and topoisomerase inhibitors. Also called rebeccamycin analog.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>NSC 655649</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de cáncer. Es un tipo de antibiótico antitumoral y de inhibidor de la topoisomerasa. También se llama análogo de la rebecamicina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-11-22</DateFirstPublished><DateLastModified>2006-11-07</DateLastModified></GlossaryTerm>
